PRVA · Privia Health Group, Inc.

Privia Health Group, Inc. delivered strong Q1 2026 results, driven by robust revenue growth of 25.8% to $603.8 million, reflecting continued strength in same-store growth and new provider additions. Practice Collections rose 14.6% to $914.8 million, supporting a 22.3% increase in Care Margin to $128.7 million and a 29.6% jump in Platform Contribution to $67.0 million. Adjusted EBITDA expanded 36.3% to $36.7 million, highlighting effective operating execution amid scaling operations. Implemented Providers grew 13.6% to 5,535, and Value-Based Care Attributed Lives surged 26.5% to 1.606 million, underscoring network expansion. Despite GAAP net income declining to $3.1 million from $4.2 million due to higher $21.9 million stock compensation expense, non-GAAP adjusted net income rose 22.3% to $24.3 million. Management maintained full-year 2026 guidance for key metrics including Adjusted EBITDA of $145-155 million and Practice Collections of $3.65-3.75 billion, while raising Attributed Lives to 1.6-1.625 million, signaling confidence in sustained momentum. Expectation of 80% Adjusted EBITDA conversion to free cash flow further bolsters cash generation outlook. Balance sheet remains solid with cash at $419.5 million as of March 31, 2026, supporting ongoing growth without new business development assumptions in guidance.